OMM-1Homo sapiens (Human)Cancer cell line
Also known as: Omm1, OMM1
AI Summary
No AI-generated summary available for this cell line.
Basic Information
Database ID | CVCL_6939 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Hypodermis[UBERON:UBERON_0002072] |
Donor Information
Age | 74 |
---|---|
Age Category | Adult |
Sex | Male |
Disease Information
Disease | Uveal melanoma |
---|---|
Lineage | Eye |
Subtype | Uveal Melanoma |
OncoTree Code | UM |
DepMap Information
Source Type | Academic lab |
---|---|
Source ID | ACH-002017_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | GNA11 | p.Gln209Leu (c.626A>T) | Unspecified | - | PubMed=22236444 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X
CSF1PO
10,12
D13S317
11,12
D16S539
9
D18S51
13,14
D21S11
30,30.2
D3S1358
14,17
D5S818
11
D7S820
13
D8S1179
10,16
FGA
20
Penta D
9,12
Penta E
5,7
TH01
7
TPOX
8,9
vWA
19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.
Roman-Roman S.
Mol. Oncol. 8:1508-1520(2014).
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity.
Salvi S., Truini M., Poggi A., Pfeffer U.
Eur. J. Cancer 49:3353-3365(2013).
Genetic and molecular characterization of uveal melanoma cell lines.
Bernatchez C., Wardell S., Bastian B.C., Woodman S.E.
Pigment Cell Melanoma Res. 25:182-187(2012).
Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.";
White J.S., Becker R.L., McLean I.W., Director-Myska A.E., Nath J.
Cancer Genet. Cytogenet. 168:11-21(2006).